Man Shu-Mei, Ma Yi-Ran, Shang De-Shu, Zhao Wei-Dong, Li Bo, Guo Da-Wen, Fang Wen-Gang, Zhu Li, Chen Yu-Hua
Department of Developmental Biology, Key Laboratory of Cell Biology, Ministry of Public Health of China, China Medical University, Shenyang 110001, PR China.
Neurobiol Aging. 2007 Apr;28(4):485-96. doi: 10.1016/j.neurobiolaging.2006.02.013. Epub 2006 Apr 5.
It is unclear how circulating T cells cross the blood-brain barrier (BBB) and participate in the inflammation process in Alzheimer's disease (AD). Here we showed significantly higher macrophage inflammatory protein-1alpha (MIP-1alpha) expression in peripheral T lymphocytes of AD patients than age-matched controls. T cells crossing of the human brain microvascular endothelial cells (HBMECs) which constitute the BBB, were almost completely abrogated by anti-MIP-1alpha antibody. MIP-1alpha induced the expression of CCR5, a potential MIP-1alpha receptor, on HBMECs. HBMECs tranfected with CCR5 resulted in increased T cells transendothelial migration. CCR5 antagonist (2D7 mAb) blocked the T cells transmigration. The MIP-1alpha-CCR5 interaction promoted T cells transendothelial migration via ROCK (Rho kinase). Furthermore, Abeta injection into rats' hippocampus induced MIP-1alpha overexpression accompanied with increased T lymphocytes occurrence in the brain cortex and this enhanced T cells entry was effectively blocked by anti-MIP-1alpha antibody. These data are the first to suggest that the interaction between MIP-1alpha overexpressed by T cells and CCR5 on HBMECs is involved in AD patients' T cells migrating from blood to brain.
目前尚不清楚循环T细胞如何穿过血脑屏障(BBB)并参与阿尔茨海默病(AD)的炎症过程。在此我们发现,AD患者外周T淋巴细胞中巨噬细胞炎性蛋白-1α(MIP-1α)的表达显著高于年龄匹配的对照组。构成血脑屏障的人脑微血管内皮细胞(HBMECs)对T细胞的通透性几乎被抗MIP-1α抗体完全消除。MIP-1α诱导HBMECs上潜在的MIP-1α受体CCR5的表达。转染CCR5的HBMECs导致T细胞跨内皮迁移增加。CCR5拮抗剂(2D7单克隆抗体)阻断T细胞迁移。MIP-1α-CCR5相互作用通过ROCK(Rho激酶)促进T细胞跨内皮迁移。此外,向大鼠海马体注射淀粉样β蛋白(Aβ)诱导MIP-1α过表达,同时大脑皮层中T淋巴细胞出现增加,而这种增强的T细胞进入被抗MIP-1α抗体有效阻断。这些数据首次表明,T细胞过度表达的MIP-1α与HBMECs上的CCR5之间的相互作用参与了AD患者T细胞从血液向大脑的迁移。